Duchenne muscular dystrophy (DMD) is a rare genetic disorder usually diagnosed in young boys, gradually weakening muscles across the body until the heart or lungs fail. Symptoms often show up by the age of 5; as the disease progresses, patients tend to lose the ability to walk around the age of 12. As per a recent analysis by DelveInsight, DMD market was USD 2,150 million in 2023 in the 7MM (The United States, Germany, France, Italy, Spain, UK, and Japan) and is expected to grow during the forecast period 2024–2034. The market is expected to see significant revenue growth due to the launch of recent exon-skipping therapies and anticipated approvals of emerging treatme...
